← CRS Congressional Research Service reports
UPDATE: All Eyes on Allergan: Drug Company’s Unprecedented Move Raises Questions for Patent and Drug Law (Part I)
LSB · Legal Sidebar · 2018-03-16 · LSB10009
Report
- CRS ID
LSB10009- Series
- Legal Sidebar
- Publication date
- 2018-03-16
Documents
- PDF
- https://www.everycrsreport.com/files/2018-03-16_LSB10009_bd4e65f214f33ced2d60fe2d238e532888396bd3.pdf
- HTML
- https://www.everycrsreport.com/files/2018-03-16_LSB10009_bd4e65f214f33ced2d60fe2d238e532888396bd3.html
- Source
- EveryCRSReport.com
- Machine
- JSON-LD · Markdown